|
|
Vaccine Detail
|
Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine |
| Vaccine Information |
- Vaccine Name: Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007293
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- GPR183
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Description: A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. (NCIT_C53443).
|
| Host Response |
|
|
| References |
NCIT_C53443: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C53443]
|
|
